These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8372050)
1. Effect of epomediol on taurocholate uptake in hepatocytes isolated from normal rats or rats with ethinyloestradiol-induced cholestasis. Barone M; Azzarone A; Angelini A; Zamparella M; Dell'Aquila P; Francavilla A Pharmacol Toxicol; 1993; 72(4-5):296-9. PubMed ID: 8372050 [TBL] [Abstract][Full Text] [Related]
2. Effect of epomediol on ethinyloestradiol-induced changes in bile acid and cholesterol metabolism in rats. Cuevas MJ; Mauriz JL; Almar M; Collado PS; González-Gallego J Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):637-42. PubMed ID: 11473529 [TBL] [Abstract][Full Text] [Related]
3. Effects of epomediol on ethinyloestradiol-induced changes in glutathione homeostasis in the rat. Cuevas MJ; Almar M; González-Gallego J Pharmacol Toxicol; 2002 Mar; 90(3):121-6. PubMed ID: 12071332 [TBL] [Abstract][Full Text] [Related]
4. Effect of ethinylestradiol and epomediol on bile flow and biliary lipid composition in rat. Rodriguez JV; Torres AM; Lunazzi G; Tiribelli C Biochem Pharmacol; 1992 Mar; 43(6):1289-93. PubMed ID: 1562282 [TBL] [Abstract][Full Text] [Related]
5. Effect of epomediol on bile flow and composition in normal rats and in rats with ethynylestradiol-induced cholestasis. Zuin M; Dioguardi ML; Festorazzi S; Podda M Farmaco Prat; 1981 Aug; 36(8):383-9. PubMed ID: 7274418 [No Abstract] [Full Text] [Related]
6. Effect of the terpenic compound epomediol on biliary secretion and bile composition in the rat. Zanninelli G; Tavanti A; Munoz ME; Ricci GL J Hepatol; 1992 Jan; 14(1):64-70. PubMed ID: 1737917 [TBL] [Abstract][Full Text] [Related]
7. Effect of epomediol on the recovery time of taurocholic acid captation in the perfused rat liver after suspension of the treatment with ethynylestradiol. Chiarantini E; Chieca R; Orlandini F; Romeo D; Buzzelli G; Gentilini P Farmaco Prat; 1986 Nov; 41(11):358-62. PubMed ID: 3803561 [No Abstract] [Full Text] [Related]
8. Enhancement of bile acid pool size, synthesis and secretion by epomediol in the rat. Mauriz JL; Cuevas MJ; El-Mir MY; Almar M; Collado PS; Gonzalez-Gallego J Dig Dis Sci; 2000 Jul; 45(7):1431-8. PubMed ID: 10961725 [TBL] [Abstract][Full Text] [Related]
9. Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. The role of liver plasma-membrane fluidity. Miccio M; Orzes N; Lunazzi GC; Gazzin B; Corsi R; Tiribelli C Biochem Pharmacol; 1989 Oct; 38(20):3559-63. PubMed ID: 2554925 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the interaction between estrogen metabolites and taurocholate for uptake into isolated hepatocytes. Lack of correlation between cholestasis and inhibition of taurocholate uptake. Brock WJ; Durham S; Vore M J Steroid Biochem; 1984 May; 20(5):1181-5. PubMed ID: 6727367 [TBL] [Abstract][Full Text] [Related]
11. Correlation of biliary epomediol-beta-glucuronide levels with bile flow enhancement in the rat. Ventura P; Lumachi B; Luzzani F; Scuri R Arzneimittelforschung; 1985; 35(10):1548-9. PubMed ID: 4074413 [TBL] [Abstract][Full Text] [Related]
12. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts. Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547 [TBL] [Abstract][Full Text] [Related]
13. [Symptomatic effect of epomediol in patients with cholestasis of pregnancy]. González M; Iglesias J; Tiribelli C; Ribalta J; Reyes H; Hernández I; Bianchi M; Andrighetti F; Molina C Rev Med Chil; 1992 May; 120(5):545-51. PubMed ID: 1343068 [TBL] [Abstract][Full Text] [Related]
14. Biotransformation of epomediol. I--Isolation and identification of main metabolites in the rat. Ventura P; Selva A Biomed Mass Spectrom; 1982 Jan; 9(1):18-21. PubMed ID: 7059659 [TBL] [Abstract][Full Text] [Related]
15. Action of acute ethanol intake on rat biliary secretion: effect of epomediol. Chiarantini E; Mazzanti R; Buzzelli G; Chieca R; Coletta D; Orlandini F; Romeo D; Arena U Farmaco Prat; 1986 Sep; 41(9):307-12. PubMed ID: 3770160 [No Abstract] [Full Text] [Related]
16. Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport. Wolf KK; Vora S; Webster LO; Generaux GT; Polli JW; Brouwer KL Toxicol In Vitro; 2010 Feb; 24(1):297-309. PubMed ID: 19706322 [TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Whiting JF; Green RM; Rosenbluth AB; Gollan JL Hepatology; 1995 Oct; 22(4 Pt 1):1273-8. PubMed ID: 7557881 [TBL] [Abstract][Full Text] [Related]
19. Hepatocyte taurocholic acid uptake in the regression of ethinyl estradiol cholestasis. Preliminary results. Chiarantini E Boll Soc Ital Biol Sper; 1984 Mar; 60(3):523-7. PubMed ID: 6712817 [TBL] [Abstract][Full Text] [Related]
20. Zonal changes of hepatobiliary taurocholate transport in intrahepatic cholestasis induced by 17 alpha-ethinyl estradiol: a histoautoradiographic study in rats. Buscher HP; Meder I; MacNelly S; Gerok W Hepatology; 1993 Mar; 17(3):494-9. PubMed ID: 8444423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]